1 Answers
Crohn's disease:
- Adult: Initially 1.5 mg/kg daily, may increase to 125 mg daily.
- Child: Initially 1.5 mg/kg daily increased to a max of 75 mg daily
Acute lymphocytic leukemia:
- Adult: Usual maintenance dose: Initially, 1.5.5 mg/kg daily as a single dose, usually used in combination with methotrexate. Dose may vary individually based on response and tolerance. Monitor blood counts at least once wkly. Withdraw treatment immedietely if there is a sharp drop in the white cell count or severe bone-marrow depression. May resume treatment slowly and carefully if white cell count remains constant for 2 days or rises. Reduce dose when used with allopurinol.
- Child: Usual maintenance dose: Initially, 1.5.5 mg/kg daily as a single dose, usually used in combination with methotrexate. Dose may vary individually based on response and tolerance. Monitor blood counts at least once wkly. Withdraw treatment immedietely if there is a sharp drop in the white cell count or severe bone-marrow depression. May resume treatment slowly and carefully if white cell count remains constant for 2 days or rises. Reduce dose when used with allopurinol.
Should be taken on an empty stomach. Best taken on an empty stomach 1 hr before or 2 hr after meals. Ensure adequate fluid intake.
Renal Impairment: Dosage may need to be reduced.
Hepatic Impairment:
- Crohn's disease: Dosage may need to be reduced.
- Acute lymphocytic leukemia: Dosage may need to be reduced
Dosage adjustment in patients with thiopurine-S-methyl transferase (TPMT) deficiency to prevent life-threatening myelotoxicity.
For patients with homozygous TPMT deficiency: Substantial reduction is required.
For patients with heterozygous TPMT deficiency: Some may require reduction but most will tolerate the usual dosages.
পুরিনেথল ট্যাবলেট সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে পুরিনেথল
1608 views
Answered